1. Given its multifaceted and dynamic nature, the world drug problem is one of the most complex challenges facing the contemporary world. It directly or indirectly a ects everyone and poses a serious threat to health, both as a result of the illicit cultivation, production, manufacture, sale, demand, tra cking and distribution of narcotic drugs and psychotropic substances, and as a consequence of the abuse of prescription drugs. e world drug problem a ects the dignity, safety and well-being of all humanity, in particular children and youth, families and communities. e drug phenomenon has a detrimental impact on social cohesion, health care, the environment, national security, regional and international stability, international peace and the sovereignty of States. It undermines respect for human rights and the rule of law, socioeconomic and political stability, democratic institutions and sustainable development. At the same time, the world drug problem is itself the result of weak rule of law, unstable socioeconomic and political conditions, poverty, marginalization and corrupt political, juridical and economic institutions. e fact that the world drug problem can be both a reason for and a result of di cult economic, social and political conditions is what makes addressing it so challenging. e fast proliferation and the extent of use of new psychoactive substances illustrates the dynamic nature of the drug problem.
2. Since the 1990s, all political declarations, action plans and resolutions adopted under the auspices of the United Nations to address the world drug problem in general have indicated the following prerequisites for successful action in tackling the drug phenomenon: full compliance with, and universal application of, the provisions of the three international drug control conventions; and the implementation of two fundamental principles, namely a common and shared responsibility for tackling the world drug problem, and a comprehensive, integrated and balanced approach to addressing the problem. None of these elements represents an incitement to an unde ned "war on drugs", nor do any of them impose a purely prohibitionist regime or condone the repression of human rights. e international drug control conventions, the ultimate goal of which is to ensure the health and welfare of humankind, constitute the agreed response of the international community to the world drug problem, and form the primary legal framework for drug control.
e principle of common and shared responsibility provides a framework for cooperation among States parties based on a shared understanding of the drug problem, a common goal and the necessity of common and coordinated action. e principle of a comprehensive, integrated and balanced approach provides the strategic direction and vision for attaining the commonly agreed goal by taking into consideration and placing appropriate emphasis on all mutually interdependent aspects of the world drug problem.
3.
e preparations for the special session of the General Assembly on the world drug problem to be held in 2016 provide the international community with an opportunity to assess the progress made in the implementation of the 2009 Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem, 4 to analyse the achievements, gaps and challenges in countering the world drug problem and to establish priorities for further action. is process is based on the outcomes of the 2014 high-level review by the Commission on Narcotic 
Chapter I.
Implementation of a comprehensive, integrated and balanced approach to addressing the world drug problem of the 2009 Political Declaration and Plan of Action. e preparatory process and the special session of the General Assembly to be held in 2016 represent good opportunities to discuss best practices and exchange views on models and methods to analyse various aspects of the world drug problem.
4.
e International Narcotics Control Board has identi ed, and continues to identify, in its annual reports and communications various gaps and challenges in implementing the international drug conventions. e Board has also emphasized the centrality of the two fundamental principles outlined in paragraph 2 above. In its annual report for 2012, the Board discussed the principle of shared responsibility in international drug control. e need to adopt a comprehensive, integrated and balanced approach to the world drug problem has been an issue that the Board has stressed continually in its activities, communications and annual reports, either in relation to various aspects of the drug problem that constitute the elements of such an approach (for example the issue of social cohesion, social disintegration and illicit drugs and the need for a multidisciplinary approach to addressing these matters) 5 or as the main topic of its annual report, as in 2004. In the light of the upcoming special session of the General Assembly on the world drug problem, the Board considers that revisiting the principle of a balanced, integrated and comprehensive approach is highly relevant in the current context, in which the di erent dimensions of the world drug problem a ect countries in diverse ways, to the extent that not only is the problem perceived di erently, but it can also have a di erent impact in each country.
A. Principle and aims

5.
e principle of a comprehensive, integrated and balanced approach to the world drug problem is strategic in nature. It requires Member States to ensure that controlled substances are available for medical and scienti c purposes. Member States should place equal emphasis on supply and demand reduction strategies, as well as on issues related to formulating a joint response to the world drug problem through international cooperation in an integrated and mutually reinforcing manner, while taking into consideration and addressing all of its aspects in a comprehensive manner. Observing and fully implementing this principle will enhance the ability of Member States to respond in a consistent and e cient manner to present and emerging challenges, and to formulate 5 Report of the International Narcotics Control Board for 2011, chap. I. policies and programmes that address the phenomenon in all its forms and manifestations.
6. e implementation of a comprehensive, integrated and balanced approach to addressing the world drug problem is not an end in itself but rather a means to an end. e ultimate goal of such an approach must be to achieve the overall aim of the drug control conventions, namely to ensure the mental and physical health and welfare of humankind. A key element in that regard, which has been politically agreed and translated into international law, is to limit the availability of controlled substances exclusively to medical and scienti c purposes, while preventing and signi cantly and measurably reducing, or eliminating, the illicit production of, tra cking in and use of such substances.
7.
e implementation of a comprehensive, integrated and balanced approach requires the full commitment of Member States to implementing the provisions of the three international drug control conventions in good faith, and the willingness and ability of Governments to take practical measures at all levels and to allocate appropriate funding for all of the elements involved, including in a situation of economic and nancial constraints.
B. Origins and development
8.
e principle of a comprehensive, integrated and balanced approach to addressing the world drug problem evolved over time.
e early drug control conventions preceding the Single Convention on Narcotic Drugs of 1961 6 focused mainly on the supply side of the drug problem. e amended version of article 38 contained in the 1972 Protocol amending the Single Convention on Narcotic Drugs of 1961 7 re ected the need to adopt a multidisciplinary approach to the problem of narcotic drugs. Article 38 stipulates the legal obligation of States to take all practicable measures for the prevention of abuse of drugs and for the early identi cation, treatment, education, a ercare, rehabilitation and social integration of the persons involved. e same provision underlines the importance of promoting both personnel training and awareness campaigns. e Commentary on the Protocol Amending the Single Convention on Narcotic Drugs, 1961, explains that article 38 re ects the general acceptance of the view that a system of administrative controls and penal sanctions for the purpose of keeping narcotic drugs from actual or potential victims is not su cient and should not form the sole subject of international cooperation. Article 38 deems drug addiction a complex problem and indicates that treatment, a ercare, rehabilitation and social reintegration represent the four stages of remedial measures that are widely held to be necessary to restore the well-being and social usefulness of persons a ected by drug addiction. 8 11 General Assembly resolution S-20/2, annex.
12 General Assembly resolution S-20/3, annex. In that Declaration, the Assembly stressed that "the most e ective approach to the drug problem consists of a comprehensive, balanced and coordinated approach, by which supply control and demand reduction reinforce each other, together with the appropriate application of the principle of shared responsibility". 13 See O cial Records of the Economic and Social Council, 2014, Supplement No. 8 (E/2014/28), chap. I, sect. C. must be not only to prevent (or at least signi cantly reduce) illicit production of, tra cking in and use of narcotic drugs and psychotropic substances, but also to facilitate the availability of controlled substances for medical and scienti c purposes. Properly implemented, such an approach must lead to an optimal balance between restrictive and facilitating measures so as to ensure the health and welfare of humankind and reduce human su ering.
11. Ensuring the availability of controlled substances for medical and scienti c purposes is a fundamental objective of the drug control system and an obligation of States parties under the international drug control conventions.
e 1961 Convention, as amended by the 1972 Protocol, and the 1971 Convention stress that medical use of narcotic drugs and psychotropic substances is indispensable for the relief of pain and su ering and that adequate provision must be made to ensure the availability of internationally controlled substances for medical and scienti c purposes. Article 9 of the 1961 Convention, as amended by the 1972 Protocol, expressly stipulates that States parties are responsible for ensuring the availability of narcotic drugs for licit purposes, and gives the Board the mandate to monitor the availability of controlled substances for legitimate purposes.
12. Acting under its mandate to assess licit consumption of controlled substances in Member States, the Board was among the rst to signal that major discrepancies existed among various regions in terms of the availability of narcotic drugs, and that inadequate access to controlled substances a ected a great number of countries. For the past two decades, the Board has paid particular attention to this concern in its relations with Governments and other relevant stakeholders, and has recommended measures to address the situation.
14 Data on the availability of opioid analgesics indicate that, despite progress made in some regions, i.e. Latin America and West, East and South-East Asia, approximately 5.5 billion people, or three quarters of the world's population, live in countries with low levels of, or non-existent, access to medicines containing narcotic drugs and have inadequate access to treatment for moderate to severe pain, while 92 per cent of the world's morphine is consumed by 17 per cent of the world's population, primarily in North America, Oceania and Western Europe. e Board also indicated on several occasions that comparable discrepancies existed in relation to access to appropriate amounts of psychotropic substances for licit purposes. 13. e analysis of the data provided by Member States shows that the amount of opiate raw material available for the production of opioid analgesics for pain relief is more than su cient to satisfy the requirements and consumption reported by Governments, and that global stocks are increasing. e low demand for opioid analgesics for pain relief in many countries is obviously not the result of a shortage of licitly produced raw materials. As the Board has repeatedly stressed, the situation could be substantially improved through corrective action by States parties to address the regulatory, attitudinal, knowledge-related, economic and procurementrelated problems identi ed as the main causes of inadequate availability of opioids. e Board encourages States to cooperate with the World Health Organization (WHO) and other relevant stakeholders on this matter, and reiterates its openness and readiness to continue assisting countries in achieving better results in this area.
To that end and as a contribution to the special session of the General Assembly on the world drug problem to be held in 2016, the Board will issue an updated version of its 2010 special report entitled Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scienti c Purposes, which will provide updated data on and analysis of the consumption and availability of internationally controlled drugs for medical and scienti c use.
14. A proper application of the international drug control conventions and the implementation of a comprehensive, integrated and balanced approach to addressing the world drug problem would promote access to appropriate amounts of controlled substances for medical and scienti c purposes and prevent the non-legitimate and excessive use of such substances.
16
Demand reduction and related measures 15.
e origin and development of the principle of a comprehensive, integrated and balanced approach to the world drug problem are strongly linked to the need to place a greater emphasis on and to mainstream demand reduction. 16 e Board has addressed, in most of its annual reports, the issue of availability of internationally controlled substances for medical and scienti c purposes, and issued recommendations in that regard. It has also repeatedly drawn attention in many of its publications to the abuse of prescription drugs, for example, by highlighting the issue under special topics in its reports for 2009, 2012 and 2013 . In 2000, the Board devoted its thematic chapter to a review of the overconsumption of internationally controlled substances; in 2013, prescription drug disposal initiatives were discussed under special topics.
16.
e Board has repeatedly stressed the importance of drug demand reduction as an indispensable element of such an approach, and has also stressed that depleting illicit supply and reducing demand have a mutually reinforcing e ect.
e Board has continually encouraged Member States to implement a comprehensive package of demand reduction measures as one of the rst priorities of their drug control policies. e Board has also clari ed that di erent approaches are required in relation to the two objectives. e legal framework for measures to counter illicit drug manufacture, production, transport, trafcking and diversion must be established at the international level. Preventing illicit drug use and abuse involves communications strategies that should take into consideration the social, cultural and economic backgrounds of the target population groups. In addition, the provision of treatment and rehabilitation for drug abusers can take place only within the existing sociocultural context of each country. Demand reduction policies and programmes, including the relevant legal frameworks, should be designed and implemented primarily at the national and local levels in order to be e ective and e cient in achieving the goals established in the international drug control conventions and related instruments. 17.
e international drug control conventions stipulate clear obligations and provide guidelines for the policies to be adopted by States parties in the eld of demand reduction. Article 38 of the 1961 Convention, as amended by the 1972 Protocol, and article 20 of the 1971 Convention stipulate that States parties shall take all practicable measures for the prevention of abuse of narcotic drugs and psychotropic substances and for the early identi cation, treatment, education, a ercare, rehabilitation and social reintegration of the persons involved. ose two articles also encourage the training of personnel involved in all stages of demand reduction activities and call for the promotion of public awareness campaigns. Article 14, paragraph 4, of the United Nations Convention against the Illicit Tra c in Narcotic Drugs and Psychotropic Substances of 1988 18 requires States parties to adopt appropriate measures aimed at eliminating or reducing illicit demand for narcotic drugs and psychotropic substances, with a view to reducing human su ering and eliminating nancial incentives for illicit tra c.
18.
e assessment of progress made in the area of demand reduction since the twentieth special session of the General Assembly, contained in the Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem, indicated that only limited results had been attained, owing largely to the lack of implementation of a comprehensive, integrated and balanced approach.
e Plan of Action stressed that Member States should "pursue a balanced and mutually reinforcing approach to supply and demand reduction, devoting more e ort to the realization of demand reduction with a view to achieving proportionality of e ort, resources and international cooperation in addressing drug abuse as a health and social issue, while upholding the law and its enforcement". 19. Demand reduction as a policy objective requires understanding drug addiction as a multifactorial health disorder that requires an evidence-based approach and involves a wide variety of complex measures that provide a continuum of education, prevention and care in health and social services, from primary prevention through early intervention to treatment, rehabilitation and social reintegration, as well as in related support services, taking into consideration the speci cities of various target groups. Access to these programmes must be provided in a non-discriminatory manner.
ese programmes and interventions should be based on appropriate evaluation and assessment of the drug situation, and should make full use of available scienti c evidence.
e evidencebased approach is equally relevant for all aspects of demand reduction. Consideration should also be given to social factors, threats to social cohesion and factors leading to social disorganization. A comprehensive approach to the demand aspect of the drug problem implies the involvement and cooperation of various actors, including educational and religious institutions; health-care, social-care, justice, enforcement and employment agencies; non-governmental organizations; and relevant civil society entities. It also implies the coordination of all of these actors, and should take full advantage of the expertise and activities of non-governmental and civil society organizations. Such an approach would further need to re ect the willingness of States parties to reorganize their priorities relating to drug control policy and allocate resources to demand reduction e orts.
Supply reduction
20. Supply reduction is another essential element of a comprehensive, integrated and balanced approach. Supply reduction strategies and measures are aimed at eliminating or signi cantly reducing the quantity of narcotic drugs and psychotropic substances available for illicit use while ensuring their availability for medical and scienti c purposes. Supply reduction measures utilizing law enforcement, judicial cooperation and sustainable alternative development programmes are designed with the purpose of combating illicit crop cultivation and dismantling organized criminal groups involved in the illicit production and tra cking of controlled substances. e long history of supply reduction e orts and the experience gained have led to the conclusion that success in reducing the availability of controlled substances for illicit use cannot be achieved without placing equal emphasis on demand reduction, making equal e orts in that regard and overcoming other root causes of the world drug problem.
21. Progress in the area of supply reduction is dependent on several factors. Of essential importance is the formulation and e ective implementation of drug supply reduction policies based on appropriate national legislation that is in full compliance with the three international drug control treaties, and provision of the proper legislative framework for international cooperation and technical assistance. e 2009 Plan of Action also identi ed other factors that needed to be addressed in order to achieve better results in the area of supply reduction, for example "inadequate information-sharing and monitoring and control mechanisms and the lack of coordinated law enforcement operations, as well as the insu cient and unstable allocation of resources".
20
22.
e proper implementation of a comprehensive, integrated and balanced approach with regard to the e orts of Member States to combat the illicit cultivation of crops and illicit drug production, manufacture, distribution and tra cking, as well as other drug-related crimes, should also facilitate e orts to respond e ectively to such new challenges as the rapid proliferation of new psychoactive substances, emerging threats from shi ing drug tra cking routes, new drug tra cking trends and the use of new communication technologies in drugrelated organized crime. Speci c e orts should be focused on comprehensive measures aimed at depriving the illicit drug economy of its commercial attractiveness, as well as at dismantling its socioeconomic basis. In this context, a comprehensive set of measures should be formulated and implemented to disrupt illicit nancial ows connected to drug tra cking, undermine links between illicit drugs and other forms of criminal activity, prevent people from being recruited by drug tra ckers by addressing the socio economic conditions that contribute to their involvement in the illicit drug economy, and strengthen ties with relevant industries to ensure the use of precursor chemicals only for licit purposes.
23. Money-laundering is a global phenomenon that has a debilitating e ect on social, political and economic stability and development. It fuels organized crime and corruption. e links between the illicit drug economy and money-laundering are well known. e rst international legal instrument to include provisions dealing with and criminalizing the laundering of money derived from illicit drug tra cking is the 1988 Convention, in its article 3, paragraph (1), and article 5. e ability to prevent and detect money-laundering represents an e ective means of identifying criminals and disrupting their activities. In their e orts to combat this phenomenon, States parties should establish or update their national legislation, enhance their cooperation and implement the relevant international instruments, such as the 1988 Convention, the United Nations Convention against Transnational Organized Crime, 21 the United Nations Convention against Corruption 22 and the International Convention for the Suppression of the Financing of Terrorism, 23 as well as the recommendations of the Financial Action Task Force on Money-Laundering. e implementation of these norms has led to improvements in the li ing of nancial secrecy in certain cases, but concerns remain, in particular in relation to o shore banking centres, or so-called nancial havens, that make criminal investigations more di cult, along with the use of the Internet and the new moneylaundering techniques that avert detection.
24.
e growing emergence in recent years of noncontrolled new psychoactive substances has become a major public health threat and a truly global phenomenon.
ese substances are o en presented as "legal" or "natural" alternatives to controlled substances, leading to the misconception that the fact that they are not controlled under the international drug control conventions makes them safe. Although it is impossible to estimate precisely the number of new psychoactive substances on the market, the United Nations O ce on Drugs and Crime (UNODC) has reported that the number of such substances in use more than doubled during the 2009-2013 period, surpassing the number of drugs that are under international control. 24 A particular challenge to the e orts of Governments in responding to the emergence of new psychoactive substances is the di culty of identifying those substances in a timely manner, given the rapid arrival of new substances on the market, the various ways these 21 substances enter the market, their inconsistent chemical composition, the lack of technical and pharmacological data and reference material, and insu cient forensic and toxicological capacity on the part of some States. e legal framework established by the international drug control treaties provides for the possibility of States adopting national control measures beyond those mandated at the international level. e monitoring and analysis of trends will also serve as a repository of information and provide a basis for e ective evidence-based policy responses. Closer cooperation among Governments at the national and international levels, as well as collaboration with UNODC and other relevant international organizations in sharing information, exchanging best practices and developing common strategies, will be crucial in addressing the global substance abuse challenge.
Socioeconomic aspects
25. Poverty, food insecurity, economic inequality, social exclusion, deprivation owing to migration and displacement, a shortage of comprehensive educational and recreational facilities and employment prospects, poor parental engagement and guidance during early childhood, and exposure to violence and abuse are some of the socioeconomic factors that have an impact on both the supply and demand sides of the drug problem, and that a ect the interaction between the two sides. ere is no direct causality between these factors and illicit drug use and abuse or involvement in the supply side, in the sense that not all people a ected by these factors are neces sarily involved in one form or another in the drug problem. However, these are important drivers of the illicit drug phenomenon and they need to be deemed as relevant elements to be taken into consideration within a comprehensive, integrated and balanced approach to the world drug problem.
26. In relation to drug control, socioeconomic aspects have been discussed mainly in the context of alternative development and treated as a matter related to supply reduction. e 2009 Plan of Action noted that there was a lack of reliable and up-to-date data on illicit crop cultivation, and no increase in and ine ective utilization of data on human development and socioeconomic aspects. 25 e report of the Board for 2005 indicated that there was no country that had thus far implemented a preventive alternative development programme, and that reactive programmes had been implemented under the most difcult conditions. e lesson learned is that these programmes need to entail a combination of incentives and disincentives-law enforcement, eradication and legitimate alternative livelihoods-and target not just communities growing illicit crops but all communities a ected by the illicit drug economy. It was noted that distinctions between consumer and producer countries were no longer relevant, and that it would be counterproductive to pursue alternative development to reduce illicit drug supply without introducing prevention and treatment programmes for drug abusers. Since then, the need for Member States to ensure the sustainability of crop control strategies, including preventive alternative development, in coordination with other development measures in order to contribute to poverty eradication and to the sustainability of social and economic development has been stated in most of the General Assembly and Commission on Narcotic Drugs resolutions on alternative development. In implementing programmes for sustainable alternative development, States parties should take into consideration the Lima Declaration on Alternative Development and the International Guiding Principles on Alternative Development, adopted at the high-level International Conference on Alternative Development in November 2012, 26 which, inter alia, stress that "an integrated and complementary approach to alternative development programmes and strategies is crucial and should be implemented in concert with broader drug control policies, including demand reduction, law enforcement, illicit crop elimination and awarenessraising, taking into account demographic, cultural, social and geographic considerations, as appropriate, and in line with the three drug conventions". 27 27. International cooperation and commitment among Governments, development organizations and international nancial institutions must be enhanced in order to ensure the sustainability of development programmes and the incorporation of drug control into the broader development agenda. Emphasis has to be placed on the a ected populations and on the provision of medical, educational and social services, the strengthening of the rule of law and the development of physical infrastructure aimed at addressing the isolation of certain areas. ose development measures should be applied in a non-discriminatory manner. In order to achieve optimal results and to re ect the needs of targeted populations, the development programmes must ensure the full participation of a ected communities, as well as national, regional and local authorities, civil society organizations and all other relevant stakeholders, at every stage, from planning to implementation to monitoring to evaluation.
e main goal of such programmes and strategies must be to create an environment in which it is 26 General Assembly resolution 68/196, annex. 27 Ibid., appendix, para. 8. possible to lead a life in which involvement in the illicit drug supply chain or illicit drug consumption is not perceived as unavoidable and is not normalized.
Sociocultural aspects
28. Cultural attitudes have a signi cant impact on the world drug problem. Certain symbolic meaning is associated with the use or non-use of narcotic drugs and psychotropic substances. Such attitudes and meanings also in uence the likelihood of a person becoming involved in illegal activities.
29. In uencing or changing people's perceptions in relation to illicit drugs is seen as mainly a prevention matter, but it is also a ected to a certain extent by the overall structure of drug control policy and the image it projects. Imbalanced approaches to di erent aspects of the drug problem could have a negative e ect on drug control policies and diminish public support for them.
30. As is the case with other phenomena, for example, the ght against corruption, the main element of sustainable success with regard to confronting the world drug problem is not reactive approaches alone but rather the fostering of a preventive culture. e Board has earlier addressed, in its report for 1997, the issue of preventing drug abuse in an environment of illicit drug promotion. In that report, the Board highlighted the need for a balanced debate and for nding the right balance between in uencing attitudes and restricting the availability of illicit drugs. e problems identi ed at that time, such as the promotion of drug use in popular culture and the relevance of education, remain relevant today. In fact, those aspects have become far more problematic and therefore should be considered elements to be addressed as an integral part of a balanced, integrated and comprehensive approach.
Security and stability
31. Security and stability are basic requirements for solving national and international problems that are of an economic, social, cultural or humanitarian nature and in promoting and encouraging respect for human rights.
32. Violence and corruption undermine the stability and legitimacy of States, including the rule of law, and in extreme cases may lead to con ict. Violence is not an inherent feature of illegal drug markets, but it can occasionally occur if certain conditions are met. Most of the violence associated with the illicit drug economy is found in regions or countries where the presence of the State or its control over territory is weak, the national institutions lack the capacity to ensure the protection of the State's citizens and to enforce the law, and respect for legal norms is low because laws appear to bene t only speci c groups and because the institutions mandated to apply those laws are mistrusted owing to their corruption, impunity and partiality. As is the case with the existence of organized criminal groups, the conditions that facilitate violence and corruption o en precede the eruption of the drug problem. In its 2010 report, the Board addressed the relationship between the illicit drug phenomenon and corruption, and stressed the highly debilitating e ect corruption has on international and national e orts to tackle the drug problem and curtail other forms of transnational organized crime. e complex relationship among many social negatives and drugs adds to the web of challenges facing all drug policy e orts.
33. Concerns related to the major challenges posed by the increasing links between drug tra cking, corruption and other forms of transnational organized crime, including tra cking in human beings, tra cking in rearms, cybercrime and, in some cases, terrorism and money-laundering, including money-laundering in connection with the nancing of terrorism, have been formulated in the two Political Declarations and reiterated by the General Assembly in its annual resolutions on international cooperation against the world drug problem. is nexus has also been a matter of concern for the Security Council for a number of years. e Council has stressed the importance, as a matter relating to the maintenance of international peace and stability, of countering the illicit production of, demand for and trafcking in drugs, and of identifying emerging trends in drug tra cking.
34. Reducing or eliminating the violence and corruption associated with the illicit drug economy must be achieved through the proper and full implementation of the international drug control conventions within the strategic framework of a comprehensive, integrated and balanced approach and the institutional strengthening required to make countries less vulnerable to external shocks, such as an increase in demand for foreign illicit drugs. e international drug control conventions have an important role to play in relation to security and stability aspects and, together with other relevant international conventions, such as the Organized Crime Convention and the Protocols thereto, 28 the Convention against Corruption and the relevant international conventions and protocols related to terrorism, they form a 28 United Nations, Treaty Series, vols. 2225 , 2237 , 2241 and 2326 comprehensive legal framework for strengthening international peace, stability and security.
D. Respect for human rights norms as an integral element of a comprehensive, integrated and balanced approach 35. One of the common elements in all declarations, action plans and resolutions that underline the principle of a comprehensive, integrated and balanced approach to addressing the world drug problem is the commitment to ensuring compliance with human rights norms. Human rights has been highlighted as a crosscutting issue for international drug policy, notably with regard to supply reduction, demand reduction and international cooperation. Even without such references, it is clear that the human rights conventions form an important cluster of binding international legislation that needs to be taken into consideration while implementing any international treaty, be it related to drugs, corruption or the environment, among other things.
36. It is notable, since 2004, how many actors critical of the existing drug control regime based at least part of their arguments on the premise that the drug control conventions would stand in contradiction to human rights norms. is human rights discourse needs to be analysed and validated through the prism of existing human rights legal norms and their authoritative interpretation by concerned human rights treaty bodies.
37.
e usage of the term human rights has to make speci c reference to legal rights as stipulated in existing international legal instruments, notably the nine core human rights conventions. 29 Moreover, the human rights treaties employ the same language and rationale as used in the preambles to the drug control treaties. is suggests a convergence rather than a divergence of human rights norms and the international drug control conventions.
38. e international drug control system was established out of concern for the health and welfare of humankind, and with the aim of meeting the medical and scienti c needs for narcotic drugs and psychotropic substances while preventing the illicit use of controlled substances. is core objective is fully supportive of the key elements-children, young people, health and wellbeing-referred to in the Political Declaration adopted by the General Assembly at its twentieth special session and in the Political Declaration on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem. It also has a direct link to human rights treaties. 30 Member States should give due consideration to the human rights norms relevant in the context of each element of a comprehensive, integrated and balanced approach, according to their legal obligations. ey should also, if necessary, seek out the advice of human rights treaty bodies for the implementation of such norms.
E. Recommendations
39.
e special session of the General Assembly on the world drug problem to be held in 2016 is critically important for readdressing the centrality of the principle of a balanced and comprehensive approach to addressing the world drug problem. It also provides a good opportunity for examining practical measures that Member States must take in order to ensure that such an approach goes beyond rhetoric and becomes the guiding principle of their drug control strategies, policies and programmes.
is should constitute one of the main criteria in judging the successes and failures of national and international drug policy and in establishing the way forward.
40. In order to assist Member States with the implementation of the principle of a balanced and comprehensive approach within the legal framework of the international drug control conventions, the International Narcotics Control Board makes the following recommendations:
30 See, for example, article 33 of the Convention on the Rights of the Child, which stipulates the legal obligation to protect children from illicit drug use and prevent the use of children in the illicit production and trafcking of such substances; article 24 of that Convention, on the right of the child to health; and article 12 of the International Covenant on Economic, Social and Cultural Rights, on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.
(a) Given that a comprehensive, integrated and balanced approach is not an end in itself but rather a strategic principle applicable within the legal framework of the international drug control conventions, the Board invites Governments to give due consideration to the universally recognized principles of international law in respecting their obligations assumed by rati cation of the drug control conventions and in interpreting the provisions of those conventions; (b) All of the elements of such an approach need to be dealt with in a balanced, multidisciplinary and comprehensive manner, involving cooperative e orts from various stakeholders at the national, regional and international levels, and could bene t from the experience and activities of religious institutions, religious leaders and relevant non-governmental and civil society organizations. To that end, the Board invites Governments to ensure and encourage the participation and cooperation of all relevant stakeholders in the strategic planning, implementation and monitoring of their drug control policies; (c) e Board invites Governments to give due consideration to their obligation to ensure the availability of controlled substances for medical and scienti c purposes. It is recommended that Member States continue and enhance their cooperation with the Board, WHO and other relevant stakeholders in this area, and make full use of the Board's 2010 special report entitled Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scienti c Purposes, and the 2012 Guide on Estimating Requirements for Substances under International Control, developed by the Board and WHO, which is aimed at assisting competent national authorities in calculating the quantities of controlled substances required for medical and scienti c purposes and in preparing the estimates and assessments of annual requirements for controlled substances;
e Board encourages Governments to ensure that demand reduction is one of the rst priorities of their drug control policies and that all aspects of the drug problem are addressed in a balanced and comprehensive manner, taking into consideration the national and local speci cities of the drug problem, and to make full use of available scienti c evidence. e Board recommends that Member States put a greater emphasis on, and provide political support and appropriate resources to, e orts relating to prevention, treatment and rehabilitation in order to achieve a balance of such e orts; (e) E orts to reduce the demand for and the supply of illicit drugs could be futile if the relevant socioeconomic factors that function as drivers of the drug problem are not addressed in an e ective and sustainable manner. e Board recommends that Governments address those factors as part of a comprehensive, integrated and balanced approach and that they incorporate drug control into the broader socioeconomic development agenda; (f) e Board encourages Governments to respect all relevant human rights norms in designing drugrelated strategies and policies, to make full use of the complex international legal framework in order to protect children from the illicit use of narcotic drugs and psychotropic substances, to prevent the use of children in the illicit production and tra cking of such substances, and to ensure that national and international drug control strategies and policies take into consideration the principle of the best interests of the child;
e most e ective approach to the world drug problem is a comprehensive, integrated and balanced one which places equal emphasis on supply and demand reduction strategies in an integrated and mutually reinforcing manner, taking into consideration other elements such as the socioeconomic, sociocultural, security and stability factors that promote the illicit demand for and supply of drugs. Such an approach requires a wide variety of complex measures. Given that some of those measures do not fall under the immediate authority and mandate of the various organizations and institutions concerned with drug control, the Board invites other United Nations organizations and bodies to become involved, in accordance with their mandates, and to use their expertise in this e ort and to support Governments in the implementation of such an approach. e Board also invites those entities to use their capacities to promote the dual aim of the drug control system, namely to ensure the availability of controlled substances for medical and scienti c purposes while preventing, signi cantly reducing or eliminating the illicit production of, tra cking in and abuse of such substances;
e Board invites Governments to use the opportunity provided by the upcoming 2016 special session of the General Assembly on the world drug problem to make a critical assessment of their drug control policies and of the extent to which the principle of a balanced, integrated and comprehensive approach is re ected in practice in their national policies and in the allocation of resources.
